Visudyne Injection, Powder, Lyophilized, For Solution
Product Images NDC 24208-560

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Visudyne (NDC 24208-560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem (Image 01)

Chemical structure diagram showing two related molecular forms labeled I and II. The structures include labeled ring systems A, B, C, and D, with various functional groups such as methoxy (OCH3), carbonyl (C=O), and amide (NH) groups. These illustrations correspond to the active ingredient verteporfin for injection in Visudyne.*

FDA Label Image

Carton (Image 02)

Packaging label for Visudyne (verteporfin for injection) 15 mg/vial, a lyophilized powder injection for intravenous infusion. The label includes dosage instructions to reconstitute and dilute before use, storage conditions, and a tamper evident seal notice. Distributed by Bausch & Lomb Americas Inc. and manufactured by Alcami Carolinas Corporation, with bar code and trademark information visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.